The object
Giovanni Traverso led development of an injectable suspension of drug crystals that self-assemble into a depot after passing through a small needle. MIT documents the material system's controlled delivery for months or potentially years and its use for contraceptive and disease-treatment applications.
What Giovanni did
Led the MIT team developing injectable drug crystals that self-assemble into a long-acting depot.
Why it matters
This manufactured injectable depot offers sustained delivery without the painful large-gauge needles typical of many long-acting formulations; it remains a research-stage technology rather than a routine treatment.
Living-status check
MIT's 24 March 2025 report names Traverso as senior author and quotes his current work; MIT's current faculty profile identifies him as a professor directing biomedical-device and drug-delivery research.